{"id":"W2138710687","doi":"10.1097/moh.0b013e32832ea2d7","title":"Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change","year":2009,"lang":"en","type":"article","venue":"Current Opinion in Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Rivaroxaban; Dabigatran; Apixaban; Medicine; Discovery and development of direct thrombin inhibitors; Warfarin; Direct thrombin inhibitor; Edoxaban; Intensive care medicine; Fondaparinux; Venous thromboembolism; Thrombin; Pharmacology; Surgery; Internal medicine; Thrombosis; Atrial fibrillation; Platelet","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00458242,0.0006598234,0.001624595,0.0007306353,0.0003995072,0.002811265,0.0009033848,0.003440385,0.003424303],"category_scores_gemma":[0.01201282,0.0002052974,0.0003681523,0.001037447,0.001699695,0.005036887,0.001004379,0.004289487,0.002400436],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009885329,"about_ca_system_score_gemma":0.00144474,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005384894,"about_ca_topic_score_gemma":0.0008842461,"domain_scores_codex":[0.9973961,0.0008319512,0.0004659938,0.0001665757,0.00101752,0.0001218423],"domain_scores_gemma":[0.9921852,0.004649688,0.0007978381,0.0001470011,0.00177297,0.0004473777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000244323,0.00006795115,0.0008908592,0.004280036,0.00007140533,0.0007122993,0.0001520157,0.0001607773,0.0006667008,0.009270261,0.1850509,0.7984324],"study_design_scores_gemma":[0.00008266687,0.0002391297,0.00167922,0.00395867,0.0001362673,0.004790507,0.0003643814,0.0002290687,0.0005022915,0.01203865,0.9759415,0.00003757841],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0006077133,0.9359106,0.000613188,0.04980486,0.01011798,0.00001116756,0.0000138327,0.00002780411,0.002892931],"genre_scores_gemma":[0.007284335,0.9109854,0.001404585,0.04052149,0.03676347,0.00002181905,0.00003227031,0.00002279856,0.002963821],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00458242,"threshold_uncertainty_score":0.02423441,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1580308792897505,"score_gpt":0.3683284313953441,"score_spread":0.2102975521055936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}